Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment

Tumor microenvironment has been implicated in tumor development and progression. As a three-dimensional tumor microenvironment model, air liquid interface (ALI) organoid culture from oncogene transgenic mouse gastrointestinal tissues was recently produced. However, ALI organoid culture system from t...

Full description

Saved in:
Bibliographic Details
Main Authors: Tatsuya Usui, Masashi Sakurai, Shuhei Enjoji, Hideyoshi Kawasaki, Koji Umata, Takashi Ohama, Nobuyuki Fujiwara, Ryotaro Yabe, Shunya Tsuji, Hideyuki Yamawaki, Shoichi Hazama, Hiroko Takenouchi, Masao Nakajima, Ryouichi Tsunedomi, Nobuaki Suzuki, Hiroaki Nagano, Koichi Sato
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2016/7053872
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558425392807936
author Tatsuya Usui
Masashi Sakurai
Shuhei Enjoji
Hideyoshi Kawasaki
Koji Umata
Takashi Ohama
Nobuyuki Fujiwara
Ryotaro Yabe
Shunya Tsuji
Hideyuki Yamawaki
Shoichi Hazama
Hiroko Takenouchi
Masao Nakajima
Ryouichi Tsunedomi
Nobuaki Suzuki
Hiroaki Nagano
Koichi Sato
author_facet Tatsuya Usui
Masashi Sakurai
Shuhei Enjoji
Hideyoshi Kawasaki
Koji Umata
Takashi Ohama
Nobuyuki Fujiwara
Ryotaro Yabe
Shunya Tsuji
Hideyuki Yamawaki
Shoichi Hazama
Hiroko Takenouchi
Masao Nakajima
Ryouichi Tsunedomi
Nobuaki Suzuki
Hiroaki Nagano
Koichi Sato
author_sort Tatsuya Usui
collection DOAJ
description Tumor microenvironment has been implicated in tumor development and progression. As a three-dimensional tumor microenvironment model, air liquid interface (ALI) organoid culture from oncogene transgenic mouse gastrointestinal tissues was recently produced. However, ALI organoid culture system from tissues of colorectal cancer patients has not been established. Here, we developed an ALI organoid model from normal and tumor colorectal tissues of human patients. Both organoids were successfully generated and showed cystic structures containing an epithelial layer and surrounding mesenchymal stromal cells. Structures of tumor organoids closely resembled primary tumor epithelium. Expression of an epithelial cell marker, E-cadherin, a goblet cell marker, MUC2, and a fibroblast marker, vimentin, but not a myofibroblast marker, α-smooth muscle actin (SMA), was observed in normal organoids. Expression of E-cadherin, MUC2, vimentin, and α-SMA was observed in tumor organoids. Expression of a cancer stem cell marker, LGR5 in tumor organoids, was higher than that in primary tumor tissues. Tumor organoids were more resistant to toxicity of 5-fluorouracil and Irinotecan than colorectal cancer cell lines, SW480, SW620, and HCT116. These findings indicate that ALI organoid culture from colorectal cancer patients may become a novel model that is useful for examining resistance to chemotherapy in tumor microenvironment.
format Article
id doaj-art-fc8bb372c4704bf9b693b80671eeaa11
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-fc8bb372c4704bf9b693b80671eeaa112025-02-03T01:32:30ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/70538727053872Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor MicroenvironmentTatsuya Usui0Masashi Sakurai1Shuhei Enjoji2Hideyoshi Kawasaki3Koji Umata4Takashi Ohama5Nobuyuki Fujiwara6Ryotaro Yabe7Shunya Tsuji8Hideyuki Yamawaki9Shoichi Hazama10Hiroko Takenouchi11Masao Nakajima12Ryouichi Tsunedomi13Nobuaki Suzuki14Hiroaki Nagano15Koichi Sato16Laboratory of Veterinary Toxicology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, JapanLaboratory of Veterinary Pathology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, JapanLaboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, JapanLaboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, JapanLaboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, JapanLaboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, JapanLaboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, JapanLaboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, JapanLaboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, JapanLaboratory of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University, Higashi 23 Bancho 35-1, Towada, Aomori 034-8628, JapanDepartment of Translational Research and Developmental Therapeutics against Cancer, School of Medicine, Yamaguchi University, 1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, JapanDepartment of Gastroenterological, Breast and Endocrine Surgery, Graduate School of Medicine, Yamaguchi University, 1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, JapanDepartment of Gastroenterological, Breast and Endocrine Surgery, Graduate School of Medicine, Yamaguchi University, 1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, JapanDepartment of Gastroenterological, Breast and Endocrine Surgery, Graduate School of Medicine, Yamaguchi University, 1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, JapanDepartment of Gastroenterological, Breast and Endocrine Surgery, Graduate School of Medicine, Yamaguchi University, 1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, JapanDepartment of Gastroenterological, Breast and Endocrine Surgery, Graduate School of Medicine, Yamaguchi University, 1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, JapanLaboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, JapanTumor microenvironment has been implicated in tumor development and progression. As a three-dimensional tumor microenvironment model, air liquid interface (ALI) organoid culture from oncogene transgenic mouse gastrointestinal tissues was recently produced. However, ALI organoid culture system from tissues of colorectal cancer patients has not been established. Here, we developed an ALI organoid model from normal and tumor colorectal tissues of human patients. Both organoids were successfully generated and showed cystic structures containing an epithelial layer and surrounding mesenchymal stromal cells. Structures of tumor organoids closely resembled primary tumor epithelium. Expression of an epithelial cell marker, E-cadherin, a goblet cell marker, MUC2, and a fibroblast marker, vimentin, but not a myofibroblast marker, α-smooth muscle actin (SMA), was observed in normal organoids. Expression of E-cadherin, MUC2, vimentin, and α-SMA was observed in tumor organoids. Expression of a cancer stem cell marker, LGR5 in tumor organoids, was higher than that in primary tumor tissues. Tumor organoids were more resistant to toxicity of 5-fluorouracil and Irinotecan than colorectal cancer cell lines, SW480, SW620, and HCT116. These findings indicate that ALI organoid culture from colorectal cancer patients may become a novel model that is useful for examining resistance to chemotherapy in tumor microenvironment.http://dx.doi.org/10.1155/2016/7053872
spellingShingle Tatsuya Usui
Masashi Sakurai
Shuhei Enjoji
Hideyoshi Kawasaki
Koji Umata
Takashi Ohama
Nobuyuki Fujiwara
Ryotaro Yabe
Shunya Tsuji
Hideyuki Yamawaki
Shoichi Hazama
Hiroko Takenouchi
Masao Nakajima
Ryouichi Tsunedomi
Nobuaki Suzuki
Hiroaki Nagano
Koichi Sato
Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment
Stem Cells International
title Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment
title_full Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment
title_fullStr Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment
title_full_unstemmed Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment
title_short Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment
title_sort establishment of a novel model for anticancer drug resistance in three dimensional primary culture of tumor microenvironment
url http://dx.doi.org/10.1155/2016/7053872
work_keys_str_mv AT tatsuyausui establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment
AT masashisakurai establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment
AT shuheienjoji establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment
AT hideyoshikawasaki establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment
AT kojiumata establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment
AT takashiohama establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment
AT nobuyukifujiwara establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment
AT ryotaroyabe establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment
AT shunyatsuji establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment
AT hideyukiyamawaki establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment
AT shoichihazama establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment
AT hirokotakenouchi establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment
AT masaonakajima establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment
AT ryouichitsunedomi establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment
AT nobuakisuzuki establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment
AT hiroakinagano establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment
AT koichisato establishmentofanovelmodelforanticancerdrugresistanceinthreedimensionalprimarycultureoftumormicroenvironment